After nearly 45 years on the cutting edge of breast cancer research, there’s always something new at the San Antonio Breast Cancer Symposium, and this year is no exception. Alongside the newest research findings and the newest breast cancer therapies, SABCS 2022 attendees will find several interesting and engaging new offerings in store for them.

‘CONTROVERSIES’ COMING TO #SABCS22

Covering some of the most talked-about topics in breast cancer care, the SABCS 2022 program includes two new “Controversies” sessions that you will not want to miss. The two new sessions—one on clinical controversies and one on translational controversies—replace the Oxford-style debate sessions from previous years and will feature “lightning discussions” between experts in the field on topics that will help to improve patient care.

Lisa Carey, MD, ScM, FASCO, of the UNC-Lineberger Comprehensive Cancer Center in Chapel Hill, N.C. will moderate the Clinical Controversies session. Komal Jhaveri, MD, FACP of Memorial Sloan Kettering Cancer Center in New York City will moderate the Translational Controversies session.

CLINICAL CONTROVERSIES:

• To Clip or Not to Clip 
  Discussants: Abigail Caudle, MD, of MD Anderson Cancer Center in Houston, and Viviana E. Galimberti, MD, MPH, of the European Institute of Oncology in Milan, Italy.
• Duration of Endocrine Therapy 
  Discussants: Kathryn Ruddy, MD, PhD, of the Mayo Clinic in Rochester, Minn., and Eleftherios “Terry” Mamounas, MD, MSc, of the Orlando Health Cancer Institute, Orlando, Fla.
• Post-neoadjuvant Therapy in TNBC 
  Discussants: Heather McArthur, MD, MPH, of UT Southwestern in Dallas, and Susan Domchek, MD, of the University of Pennsylvania School of Medicine in Philadelphia.

TRANSLATIONAL CONTROVERSIES:

• RIP MTD 
  Discussants: Hope S. Rugo, MD, FASCO, of the University of California San Francisco, and Geoffrey Shapiro, MD, PhD, of the Dana-Farber Cancer Institute.
• Randomized Trials Versus Real World Evidence 
  Discussants: Angela DeMichele, MD, MSCE, of the University of Pennsylvania in Philadelphia, and Sean Khozin, MD, MPH, of CancerLinQ, LLC in New York City.
• Ki-67 
  Discussants: Nadia Harbeck, MD, PhD, of LMU University Hospital in Munich, and Torsten Nielsen, MD, PhD, FRCPC, of the University of British Columbia in Vancouver, British Columbia.

SPECIAL SESSION ON DIVERSITY

As part of SABCS’s ongoing commitment to health equity, diversity, and inclusion, this year’s program includes an important Special Session on Diversity to be held on Tuesday, December 6. Serving as co-chairs and panelists for the session will be Thelma Brown, BSc, University of Alabama at Birmingham; Maimah Karmo, BS, Tigerlily Foundation; Charles Perou, PhD, University of North Carolina at Chapel Hill; Patty Spears, BS, University of North Carolina at Chapel Hill. Stay tuned to SABCS Meeting News for more information on this session.

SABCS ‘BREAST CANCER TRANSLATED’ PODCAST SERIES

The San Antonio Breast Cancer Symposium is extending its commitment to year-round content with its new “Breast Cancer Translated” podcast series. Through this podcast series, leading physicians and scientists will explore the rapidly changing nature of current issues through robust conversations on hot topics in medicine, healthcare, and education.

In Episode 1: The Carolina Breast Cancer Study, SABCS Program Director Kate Lathrop, MD, interviews Melissa Troester, PhD, of the Gillings School of Public Health at the University of North Carolina in Chapel Hill. Together they review the background of the study, the translational science that developed as a result, how the findings can impact public health policy and the care of African American women with breast cancer, with the goal to help bridge this gap in breast cancer-related mortality.

The episode is available on the SABCS website and on the SABCS YouTube channel. Make sure you subscribe to the channel for notifications of new episodes.